Perseon registers $33.09 million of stock for public sale of its units

Shares and five-year warrants sold to finance research and development

By Devika Patel

Knoxville, Tenn., April 23 – Perseon Corp. will sell units of one common share and one warrant in a public offering with a 45-day greenshoe, according to a Form S-1 filed Thursday with the Securities and Exchange Commission. The company has registered up to $33.09 million of stock for the sale, which includes $16.1 million of stock underlying the five-year warrants.

Maxim Group LLC is the bookrunner.

Proceeds will be used for research and development, marketing, selling and general working capital.

The Salt Lake City life sciences company develops, manufactures, markets and services systems to treat cancer and other diseases with heat therapy using focused radiofrequency and microwave energy.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.